Journal of Infectious Diseases & Therapy
Open Access

Case Report

Metadichol^® and MRSA Infections: A Case Report

PR Raghavan^*

Nanorx Inc, PO Box 131, Chappaqua, NY 10514, USA

*Corresponding Author:

PR Raghavan
Nanorx Inc, PO Box 131, Chappaqua
NY 10514, USA
E-mail: raghavan@nanorxinc.com

Received date: April 17, 2017; Accepted date: April 21, 2017; Published date: April 24, 2017

Citation: Raghavan PR (2017) Metadichol^® and MRSA Infections: A Case Report. J Infect Dis Ther 5:317. doi:10.4172/2332-0877.1000317

Copyright: © 2017 Raghavan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Metadichol® [1] is a Nanoemulsion of long-chain alcohols called as Policosanol and is present in foods such as rice, sugar cane, wheat, and peanuts. Metadichol® acts on Nuclear Vitamin D receptors (VDR) that have a ubiquitous presence in cells and tissues of the body to stimulate the immune system and inhibit a variety of disease processes, resulting from viral, bacterial and parasitic infections. Infectious agents can cause disease by avoiding normal host defense mechanisms or by subverting them to promote their replication. They do so by blocking VDR receptor that is responsible for innate immunity, and this suppression of the immune response leads to persistent infections.

We present a case study of a patient who had acquired MRSA infections and how Metadichol® by its actions on the VDR has resolved the problem of this deadly disease without any side effects.

Keywords